Black D, Reid I, Napoli N, Ewing S, Shiraki M, Nakamura T
J Bone Miner Res. 2021; 37(1):21-28.
PMID: 34585443
PMC: 10441037.
DOI: 10.1002/jbmr.4434.
Martinez-Garcia G, Perez R, Fernandez A, Durand S, Kroemer G, Marino G
Metabolites. 2021; 11(8).
PMID: 34436422
PMC: 8399495.
DOI: 10.3390/metabo11080481.
Walsh J, Jacques R, Schomburg L, Hill T, Mathers J, Williams G
Lancet Healthy Longev. 2021; 2(4):e212-e221.
PMID: 33842907
PMC: 8020713.
DOI: 10.1016/S2666-7568(21)00051-9.
Ma R, Wu M, Li Y, Wang J, Yang P, Chen Y
J Orthop Surg Res. 2021; 16(1):195.
PMID: 33731168
PMC: 7968280.
DOI: 10.1186/s13018-021-02343-3.
Yao S, Laurent C, Roh J, Lo J, Tang L, Hahn T
Breast Cancer Res Treat. 2020; 180(1):187-195.
PMID: 31912328
PMC: 7171589.
DOI: 10.1007/s10549-019-05518-z.
Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials.
Kim T, Bauer D, McNabb B, Schafer A, Cosman F, Black D
J Bone Miner Res. 2018; 34(5):810-816.
PMID: 30536713
PMC: 10463267.
DOI: 10.1002/jbmr.3654.
Efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: A systematic review and meta-analysis.
Peng L, Luo Q, Lu H
Medicine (Baltimore). 2017; 96(49):e8659.
PMID: 29245225
PMC: 5728840.
DOI: 10.1097/MD.0000000000008659.
Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.
Greenblatt M, Tsai J, Wein M
Clin Chem. 2016; 63(2):464-474.
PMID: 27940448
PMC: 5549920.
DOI: 10.1373/clinchem.2016.259085.
Combination of micellar casein with calcium and vitamins D2 and K2 improves bone status of ovariectomized mice.
Boulier A, Schwarz J, Lespesailles E, Baniel A, Tome D, Blais A
Osteoporos Int. 2016; 27(10):3103-12.
PMID: 27222105
DOI: 10.1007/s00198-016-3638-z.
The management of osteoporosis in children.
Ward L, Konji V, Ma J
Osteoporos Int. 2016; 27(7):2147-2179.
PMID: 27125514
DOI: 10.1007/s00198-016-3515-9.
The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study.
Bae S, Lee S, Ahn S, Kim H, Kim B, Koh J
Osteoporos Int. 2016; 27(8):2533-41.
PMID: 26984570
DOI: 10.1007/s00198-016-3565-z.
Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density.
Natsag J, Kendall M, Sellmeyer D, McComsey G, Brown T
HIV Med. 2015; 17(3):196-205.
PMID: 26177791
PMC: 4715784.
DOI: 10.1111/hiv.12291.
Treatment failure in osteoporosis.
Diez-Perez A, Adachi J, Agnusdei D, Bilezikian J, Compston J, Cummings S
Osteoporos Int. 2012; 23(12):2769-74.
PMID: 22836278
DOI: 10.1007/s00198-012-2093-8.
Efficacy of intravenously administered ibandronate in postmenopausal Korean women with insufficient response to orally administered bisphosphonates.
Bae S, Kim B, Lim K, Lee S, Kim H, Kim G
J Bone Miner Metab. 2012; 30(5):588-95.
PMID: 22610063
DOI: 10.1007/s00774-012-0361-5.
Clinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy.
Schousboe J, Bauer D
Curr Osteoporos Rep. 2012; 10(1):56-63.
PMID: 22286411
PMC: 4004108.
DOI: 10.1007/s11914-011-0091-y.
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
Vasikaran S, Eastell R, Bruyere O, Foldes A, Garnero P, Griesmacher A
Osteoporos Int. 2010; 22(2):391-420.
PMID: 21184054
DOI: 10.1007/s00198-010-1501-1.
Bone physiology, disease and treatment: towards disease system analysis in osteoporosis.
Post T, Cremers S, Kerbusch T, Danhof M
Clin Pharmacokinet. 2010; 49(2):89-118.
PMID: 20067335
DOI: 10.2165/11318150-000000000-00000.
Bone markers in osteoporosis.
Garnero P
Curr Osteoporos Rep. 2009; 7(3):84-90.
PMID: 19723466
DOI: 10.1007/s11914-009-0014-3.
Bone turnover markers: understanding their value in clinical trials and clinical practice.
Civitelli R, Armamento-Villareal R, Napoli N
Osteoporos Int. 2009; 20(6):843-51.
PMID: 19190842
DOI: 10.1007/s00198-009-0838-9.
Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.
Szulc P, Delmas P
Osteoporos Int. 2008; 19(12):1683-704.
PMID: 18629570
DOI: 10.1007/s00198-008-0660-9.
